BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 15293705)

  • 21. Melanoma of the feet: misdiagnosed and misunderstood.
    Albreski D; Sloan SB
    Clin Dermatol; 2009; 27(6):556-63. PubMed ID: 19880043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome.
    Woo DK; Jones CR; Vanoli-Storz MN; Kohler S; Reddy S; Advani R; Hoppe RT; Kim YH
    Arch Dermatol; 2009 Jun; 145(6):667-74. PubMed ID: 19528422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic significance of some markers in cutaneous melanoma treated with different therapeutic modalities].
    Nepomniashchaia EM; Gusareva MA; Petrov SV
    Vopr Onkol; 2008; 54(6):744-8. PubMed ID: 19241851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined treatment of patients with metastases of skin melanoma using cryotherapy].
    Iavorskiĭ VV; Karaseva VV; Tokareva ZI
    Vopr Onkol; 1988; 34(7):799-803. PubMed ID: 3420821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women?
    Hofmann MA; Coll SH; Küchler I; Kiecker F; Wurm R; Sterry W; Trefzer U
    Dermatology; 2007; 215(1):10-6. PubMed ID: 17587834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention and treatment of regional lymphatic metastasis of cutaneous melanoma].
    Korovin SI; Tolstopiatov BA
    Klin Khir (1962); 1993; (5):34-6. PubMed ID: 7933861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined and complex treatment of patients with II-stage malignant skin melanoma using hyperthermia].
    Zhavrid EA; Fradkin SZ; Bezruchko VI; Firmanchuk AV; Proleskovskiĭ AK
    Vopr Onkol; 1986; 32(3):52-7. PubMed ID: 3962258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma.
    Richtig E; Ludwig R; Kerl H; Smolle J
    Br J Dermatol; 2005 Nov; 153(5):925-31. PubMed ID: 16225601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination immunotherapy breakthrough for melanoma.
    Brower V
    Lancet Oncol; 2015 Jul; 16(7):e318. PubMed ID: 26062775
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognosis of patients with advanced melanoma.
    Eberlein TJ
    J Am Coll Surg; 1995 Sep; 181(3):263-5. PubMed ID: 7670686
    [No Abstract]   [Full Text] [Related]  

  • 31. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
    Kudriavtsev DV; Kudriavtseva GT; Mardynskiĭ IuS
    Vopr Onkol; 2008; 54(2):170-7. PubMed ID: 18522165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitiligo: a good prognostic factor in melanoma?
    Cunha D; Pacheco FA; Cardoso J
    Dermatol Online J; 2009 Feb; 15(2):15. PubMed ID: 19336032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and treatment of malignant melanoma of the skin (a lecture)].
    Denisov LE; Kurdina MI
    Khirurgiia (Mosk); 1996; (1):17-22. PubMed ID: 8683912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant therapy in melanoma. Part I: Background, chemotherapy, radiation, and nonspecific immunotherapy.
    Elias EG
    Md Med J; 1990 May; 39(5):489-90. PubMed ID: 2185395
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of melanoma metastases confined to the liver and future perspectives.
    Vahrmeijer AL; van de Velde CJ; Hartgrink HH; Tollenaar RA
    Dig Surg; 2008; 25(6):467-72. PubMed ID: 19212119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The present status of the multidisciplinary treatment of malignant melanoma].
    Ishihara K; Hayasaka K; Ikegawa S; Kageshita T
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1073-8. PubMed ID: 4057571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis, treatment and follow-up of primary malignant skin melanoma].
    Ketterer R
    Rev Med Suisse Romande; 1995 Oct; 115(10):753-7. PubMed ID: 7501925
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.